huCART19 is a CD19 targeted CAR T Cell therapy being developed at The University of Pennsylvania.
| SparkCures ID | 332 |
|---|---|
| Generic Name | huCART19 |
| Treatment Classifications | |
| Treatment Targets |
There are no resources, links or videos to display for this treatment.